Jailendra Singh
Stock Analyst at Truist Securities
(0.94)
# 3,780
Out of 4,902 analysts
179
Total ratings
29.03%
Success rate
-23.5%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $36.82 | +38.51% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $22.18 | +21.73% | 10 | Jul 17, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $45 → $48 | $49.08 | -2.20% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $9.74 | +64.36% | 6 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $59.34 | +2.80% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $47.02 | +2.08% | 1 | Jun 16, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $24.91 | +40.51% | 6 | May 29, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $9 | $7.89 | +14.07% | 16 | May 27, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $333 → $300 | $315.22 | -4.83% | 4 | Apr 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $263 → $216 | $161.53 | +33.72% | 15 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $262 → $208 | $145.12 | +43.33% | 9 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $20.19 | +38.68% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.75 | +15.91% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $7.99 | -6.13% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $23.30 | +97.42% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $278.70 | -24.65% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $12.96 | +8.02% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $2.14 | +203.74% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $3.73 | +248.53% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $7.93 | +442.59% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.96 | +506.83% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.16 | +85.61% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $158.96 | -63.51% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $5.97 | +653.77% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $709.42 | -53.06% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.02 | +198.01% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $20.95 | - | 3 | Jan 15, 2021 |
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $36.82
Upside: +38.51%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $22.18
Upside: +21.73%
Hims & Hers Health
Jul 17, 2025
Maintains: Hold
Price Target: $45 → $48
Current: $49.08
Upside: -2.20%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $9.74
Upside: +64.36%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $59.34
Upside: +2.80%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $47.02
Upside: +2.08%
Phreesia
May 29, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $24.91
Upside: +40.51%
Teladoc Health
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.89
Upside: +14.07%
Medpace Holdings
Apr 23, 2025
Maintains: Hold
Price Target: $333 → $300
Current: $315.22
Upside: -4.83%
IQVIA Holdings
Apr 10, 2025
Maintains: Buy
Price Target: $263 → $216
Current: $161.53
Upside: +33.72%
Apr 10, 2025
Maintains: Buy
Price Target: $262 → $208
Current: $145.12
Upside: +43.33%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $20.19
Upside: +38.68%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.75
Upside: +15.91%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $7.99
Upside: -6.13%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $23.30
Upside: +97.42%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $278.70
Upside: -24.65%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $12.96
Upside: +8.02%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $2.14
Upside: +203.74%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $3.73
Upside: +248.53%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $7.93
Upside: +442.59%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.96
Upside: +506.83%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.16
Upside: +85.61%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $158.96
Upside: -63.51%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $5.97
Upside: +653.77%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $709.42
Upside: -53.06%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.02
Upside: +198.01%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $20.95
Upside: -